Clinical Performance of Stenfilcon A Versus Filcon II 3
Sponsor: CooperVision, Inc.
A NA clinical study on Myopia, this trial is completed. The trial is conducted by CooperVision, Inc. and has accumulated 8 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
May 2025 — Present [monthly]
Completed NA
-
Jan 2025 — May 2025 [monthly]
Completed NA
-
Sep 2024 — Jan 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Completed NA
Phase: PHASE4 → NA
-
Jun 2018 — Sep 2020 [monthly]
Completed PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CooperVision, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .